NEW YORK (Reuters Health) – Intraperitoneal chemotherapy may significantly improve long-term survival in ovarian cancer patients, a new study found. Data from 876 patients followed for a median…
Herbert Lepor, MD, and Danil V. Makarov, MD, MHS, discuss the case of a 58 year-old African American male with lower urinary tract symptoms in Part 1 of…
NEW YORK (Reuters Health) – Anticoagulant use may be a predictor of overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel, retrospective data suggest. The…
NEW YORK (Reuters Health) – Transplantation of hematopoietic cells from a donor with a single matched HLA haplotype, combined with post-transplant cyclophosphamide, may be a good alternative when…
NEW YORK (Reuters Health) – Symptomatic lymphoceles that develop after retroperitoneal lymph node dissection in gynecologic cancer patients can be dealt with safely and effectively by laparoscopic lymphocele…
NEW YORK (Reuters Health) – TNFerade biologic, a novel method of delivering tumor necrosis factor to tumor cells by gene transfer, does not prolong survival when added to…
NEW YORK (Reuters Health) – Aggressive CT or PET/CT surveillance protocols confer significant risk of radiation-induced cancer in patients being monitored for metastasis from primary choroidal melanoma, California-based…
NEW YORK (Reuters Health) – In HIV patients with anal intraepithelial neoplasia (AIN), infrared coagulation (IRC) helps avoid progression to squamous cell carcinoma (SCC), Spanish doctors say. “High-grade…
NEW YORK (Reuters Health) – Men with isolated high-grade prostatic intraepithelial neoplasia (HGPIN) are at relatively high risk for developing prostate cancer, and treatment with toremifene does not…
NEW YORK (Reuters Health) – Among patients undergoing liver transplantation for hepatocellular carcinoma, the risk of recurrence is lower when immunosuppression is based on sirolimus rather than calcineurin…
